Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Cauli

Showing results (111-120 of 180) with videos related to

Pageof 18
Sort By:
Annals of the Rheumatic Diseases|October 5, 2019
Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)Gloria Lliso-Ribera, Frances Humby, Myles Lewis, et al.
Journal of Clinical Medicine|September 28, 2023
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic CohortAlberto Floris, Cristina Mugheddu, Leonardo Sichi, et al.
European Journal of Internal Medicine|July 12, 2022
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritisGian Luca Erre, Fabio Cacciapaglia, Garifallia Sakellariou, et al.
European Journal of Internal Medicine|October 18, 2021
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study GroupFabio Cacciapaglia, Francesca Romana Spinelli, Matteo Piga, et al.
Rheumatology (Oxford, England)|May 30, 2024
Exploring relief for Behçet's disease refractory oral ulcers: a comparison of TNF inhibitors versus apremilastGiuseppe Lopalco, Maria Morrone, Vincenzo Venerito, et al.
Mediators of Inflammation|February 28, 2018
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional StudyGian Luca Erre, Matteo Piga, Anna Laura Fedele, et al.
Frontiers in Medicine|March 26, 2024
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registryAndreina Manfredi, Marco Fornaro, Chiara Bazzani, et al.
Arthritis Research & Therapy|November 26, 2020
Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohortAlberto Floris, Gerard Espinosa, Luisa Serpa Pinto, et al.
Clinical and Experimental Rheumatology|July 25, 2024
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registryMaria Sole Chimenti, Mauro Fatica, Marco Fornaro, et al.
The Journal of Rheumatology|February 16, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.
Pageof 18

Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
Annals of the Rheumatic Diseases|October 5, 2019
Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)Gloria Lliso-Ribera, Frances Humby, Myles Lewis, et al.
Journal of Clinical Medicine|September 28, 2023
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic CohortAlberto Floris, Cristina Mugheddu, Leonardo Sichi, et al.
European Journal of Internal Medicine|July 12, 2022
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritisGian Luca Erre, Fabio Cacciapaglia, Garifallia Sakellariou, et al.
European Journal of Internal Medicine|October 18, 2021
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study GroupFabio Cacciapaglia, Francesca Romana Spinelli, Matteo Piga, et al.
Rheumatology (Oxford, England)|May 30, 2024
Exploring relief for Behçet's disease refractory oral ulcers: a comparison of TNF inhibitors versus apremilastGiuseppe Lopalco, Maria Morrone, Vincenzo Venerito, et al.
Mediators of Inflammation|February 28, 2018
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional StudyGian Luca Erre, Matteo Piga, Anna Laura Fedele, et al.
Frontiers in Medicine|March 26, 2024
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registryAndreina Manfredi, Marco Fornaro, Chiara Bazzani, et al.
Arthritis Research & Therapy|November 26, 2020
Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohortAlberto Floris, Gerard Espinosa, Luisa Serpa Pinto, et al.
Clinical and Experimental Rheumatology|July 25, 2024
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registryMaria Sole Chimenti, Mauro Fatica, Marco Fornaro, et al.
The Journal of Rheumatology|February 16, 2021
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingCarmel Stober, Deepak R Jadon, April W Armstrong, et al.
Pageof 18